FDA Drug Application (021036) for RELENZA by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number021036
Product Number001
FormPOWDER;INHALATION
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRELENZA
Active IngredientZANAMIVIR



Back to FDA Applications sponsored by GLAXOSMITHKLINE